QuickView for low-density lipoprotein particle receptor catabolic process (biogroup)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Bone marrow CD34 cells treated with small molecule perturbagens
3. MicroRNA profiling of primary high-grade soft tissue sarcomas
4. Neural development of iPSCs derived from Autistic patients with BCKD-kinase mutations
5. L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens

There were no matches for low-density lipoprotein particle receptor catabolic process

1. Comparison of Simvastatin Versus Simvastatin/Ezetimibe on Small Dense Low -Density Lipoprotein (LDL)
2. A Mechanistic Study of the Effects of LY518674 on High-Density Lipoprotein Cholesterol (HDL-C) Metab…
3. In Vivo Metabolism of apoB-containing Lipoproteins in ANGPTL3 Deficient Subjects
4. A Long-term Follow-up Study to Evaluate the Safety and Efficacy of RGX-501
5. Influence of Simvastatin on Apolipoprotein B-100 (apoB-100) Secretion